Since 1967, the lives of countless babies have been saved by the pioneering Rh Program - and to date, over three million doses of anti-D have been given to Rh negative women.

The program provides plasma collected from blood donors with anti-D for production of anti-D immunoglobulin for treatment of RhD negative women with babies at risk of haemolytic disease of the fetus and newborn (HDFN).

We're celebrating this 50-year milestone with two presentations commemorating the RhD Program and looking at the prevention of Rh HDFN.

Click here to view 'The RhD Program - 50 years of preventing Haemolytic Disease of the Fetus and Newborn (HDFN)' and 'Prevention of Rh HDFN: The Australian Anti-D Program'.